Version July 2025
| Agents | Brand names | Dosing |
| Combination LAMA-LABA inhalers | ||
| Aclidinium 400 mcg/formoterol fumarate 12 mcg | Duaklir Genuair (Canada) Duaklir Pressair (United States) | 1 inhalation twice daily; DPI |
| Glycopyrrolate (as glycopyrronium) 50 mcg/indacaterol 110 mcg* | Ultibro Breezhaler (Canada) | 1 capsule (inhalation only), once daily; DPI |
| Glycopyrrolate 9 mcg/formoterol fumarate 4.8 mcg | Bevespi Aerosphere (United States) | 2 inhalations twice daily; pMDI |
| Tiotropium 2.5 mcg/olodaterol 2.5 mcg per actuation | Stiolto Respimat (United States) Inspiolto Respimat (Canada) | 2 inhalations once daily; SMI |
| Umeclidinium 62.5 mcg/vilanterol 25 mcg | Anoro Ellipta (United States and Canada) | 1 inhalation once daily; DPI |
| LAMA-LABA-ICS inhalers | ||
| Fluticasone furoate 100 mcg/umeclidinium 62.5 mcg/vilanterol 25 mcg | Trelegy Ellipta (United States) | 1 inhalation once daily; DPI |
| Budesonide 160 mcg/glycopyrrolate 9 mcg/formoterol fumarate 4.8 mcg¶ | Breztri Aerosphere (United States and Canada) | 2 inhalations twice daily; MDI |
DPI: dry powder inhaler; ICS: inhaled glucocorticoid (aka, inhaled corticosteroid); LABA: long-acting beta agonist; LAMA: long-acting muscarinic antagonist; pMDI: pressurized metered dose inhaler; SMI: soft mist inhaler
* Glycopyrrolate 15.6 mcg/indacaterol 27.5 mcg (Utibron Neohaler), although approved by the US Food and Drug Administration, is not available in the United States. Strength shown is for the Ultibro Breezhaler available in Canada.
¶ In Canada, Breztri Aerosphere is labeled as mcg of budesonide, glycopyrronium, and formoterol fumarate dihydrate. The budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg inhaler delivers the same dose as listed in the table.
